Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan. (Q51570683)
Jump to navigation
Jump to search
scientific article published in November 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan. |
scientific article published in November 1997 |
Statements
Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan. (English)
1 reference
Yamasaki Y
1 reference
Kawamori R
1 reference
Wasada T
1 reference
Sato A
1 reference
Omori Y
1 reference
Eguchi H
1 reference
Tominaga M
1 reference
Sasaki H
1 reference
Ikeda M
1 reference
Kubota M
1 reference
Ishida Y
1 reference
Hozumi T
1 reference
Baba S
1 reference
Uehara M
1 reference
Shichiri M
1 reference
Kaneko T
1 reference
1 November 1997
1 reference
183
1 reference
3
1 reference
173-183
1 reference